TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

TransMedics Group, a leader in organ transplant technology, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 7:30 a.m. EST. The virtual event aims to showcase the company's advancements in portable warm perfusion and assessment of donor organs for transplantation. Founded to enhance organ availability and quality, TransMedics is dedicated to addressing the needs of patients with end-stage heart, lung, and liver failure. Interested parties can access the presentation live and archived on the TransMedics website.

News Market Reaction – TMDX

-0.43%

-0.43% Session move

In the trading session that priced this news, TMDX declined 0.43%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Dec. 22, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming 40^th Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 12, 2022, at 7:30 a.m. Eastern Standard Time.

Event: 40^th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 12, 2022
Time: 7:30 a.m. EST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
631-807-1986
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301449226.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics scheduled to present at the J.P. Morgan Healthcare Conference?

TransMedics is scheduled to present on January 12, 2022, at 7:30 a.m. EST.

Where can I watch the TransMedics presentation at the J.P. Morgan Healthcare Conference?

You can watch the live and archived webcast of the presentation on the TransMedics website.

What technologies does TransMedics focus on for organ transplantation?

TransMedics focuses on portable extracorporeal warm perfusion and assessment of donor organs to improve organ quality and viability.

What is the goal of TransMedics in the organ transplant field?

TransMedics aims to address the unmet need for more and better organs for transplantation, particularly for patients with end-stage heart, lung, and liver failure.